The invention relates to novel phenanthridine derivatives and to medicaments, which are for use in antitumoral therapy and prophylaxis and which contain these phenanthridine derivatives. It could be shown that up to now specifically substituted phenanthridine derivatives of the prior art neither have a known nor an antitumoral activity that is to be expected.
本发明涉及新型
菲啶衍
生物以及用于抗肿瘤治疗和预防并含有这些
菲啶衍
生物的药物。迄今为止,现有技术中的特异性取代
菲啶衍
生物既不具有已知的抗肿瘤活性,也不具有预期的抗肿瘤活性。